Abundant transmission of Corona Virus Nsp2 RNA Topoisomerse I120F Mutants with Concurrence D614G Spike Protein Mutation in Australia

A. Chakraborty
{"title":"Abundant transmission of Corona Virus Nsp2 RNA Topoisomerse I120F Mutants with Concurrence D614G Spike Protein Mutation in Australia","authors":"A. Chakraborty","doi":"10.35248/1948-5964.13.S16.001","DOIUrl":null,"url":null,"abstract":"We previously predicted Nsp2 Corona virus protein as RNA topoisomerase through amino acid homology among Vibrio haemolytica DNA topoisomerase IA/IV as well as DNA primase, DNA gyrase and bi-subunit Trypanosoma brucei DNA topoisomerase IB. Many DNA topoisomerase I/III have RNA topoisomerase activity and such ubiquitous enzymes are conserved and involved in the regulation of replication and transcription. We have checked here mutational profile of Nsp2 RNA topoisomerase analyzing >10000 orf1a 4405 amino acid length Corona virus polyprotein. Mutant proteins were selected by BLAST search having 99.84% sequence similarity and 181-818aa portion Nsp2 protein (protein id. QIU82057) was analyzed using CLUSTAL Omega software. We found 26 different mutations where most changes were selected at Isoleucine and Alanine into Valine or Leucine into Phenylanaline pinpointing conserved nature of the Corona virus RNA topoisomerase. Major nonsense very abundant mutations were found at I120F (Isoleucine to Phenylalanine). Other important mutations were R27C, I198V, T85I, L410F, I559V and P583S. The I120F mutation was abundant in Australian isolates and its spread was seen in the Bangladesh and other countries like USA. We suggest that abundant I120F mutation of Nsp2 Topoisomerase may increase transmission of Corona virus by stabilizing RNA structure for efficient virus pakaging. Interestingly, such mutations were found in association of D614G mutation of Spike protein, known to >70% increase infectivity. On the contrary, all P583S Nsp2 mutants analyzed had no concurrence D614G spike protein mutation. Many silent mutations (5-7) were detected by genome wide analysis but no N501Y Spike protein mutation. This is first report that predicts a link of greater Corona virus transmission with Nsp2 protein I120F and spike protein D614G mutations.","PeriodicalId":15020,"journal":{"name":"Journal of Antivirals & Antiretrovirals","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antivirals & Antiretrovirals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/1948-5964.13.S16.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We previously predicted Nsp2 Corona virus protein as RNA topoisomerase through amino acid homology among Vibrio haemolytica DNA topoisomerase IA/IV as well as DNA primase, DNA gyrase and bi-subunit Trypanosoma brucei DNA topoisomerase IB. Many DNA topoisomerase I/III have RNA topoisomerase activity and such ubiquitous enzymes are conserved and involved in the regulation of replication and transcription. We have checked here mutational profile of Nsp2 RNA topoisomerase analyzing >10000 orf1a 4405 amino acid length Corona virus polyprotein. Mutant proteins were selected by BLAST search having 99.84% sequence similarity and 181-818aa portion Nsp2 protein (protein id. QIU82057) was analyzed using CLUSTAL Omega software. We found 26 different mutations where most changes were selected at Isoleucine and Alanine into Valine or Leucine into Phenylanaline pinpointing conserved nature of the Corona virus RNA topoisomerase. Major nonsense very abundant mutations were found at I120F (Isoleucine to Phenylalanine). Other important mutations were R27C, I198V, T85I, L410F, I559V and P583S. The I120F mutation was abundant in Australian isolates and its spread was seen in the Bangladesh and other countries like USA. We suggest that abundant I120F mutation of Nsp2 Topoisomerase may increase transmission of Corona virus by stabilizing RNA structure for efficient virus pakaging. Interestingly, such mutations were found in association of D614G mutation of Spike protein, known to >70% increase infectivity. On the contrary, all P583S Nsp2 mutants analyzed had no concurrence D614G spike protein mutation. Many silent mutations (5-7) were detected by genome wide analysis but no N501Y Spike protein mutation. This is first report that predicts a link of greater Corona virus transmission with Nsp2 protein I120F and spike protein D614G mutations.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冠状病毒Nsp2 RNA拓扑异构体I120F突变体并发D614G刺突蛋白突变在澳大利亚的大量传播
我们之前通过溶血弧菌DNA拓扑异构酶IA/IV、DNA引物酶、DNA回转酶和双亚基布氏锥虫DNA拓扑异构酶IB的氨基酸同源性预测Nsp2冠状病毒蛋白为RNA拓扑异构酶,许多DNA拓扑异构酶I/III具有RNA拓扑异构酶活性,这些酶是普遍存在的,并参与复制和转录的调控。我们在这里检查了Nsp2 RNA拓扑异构酶的突变谱,分析了>10000 orf1a 4405氨基酸长度的冠状病毒多蛋白。BLAST搜索得到序列相似度为99.84%、Nsp2蛋白181-818aa部分(蛋白id)的突变蛋白。采用CLUSTAL Omega软件对QIU82057进行分析。我们发现了26个不同的突变,其中异亮氨酸和丙氨酸被选择为缬氨酸或亮氨酸被选择为苯analine,从而确定了冠状病毒RNA拓扑异构酶的保守性。在I120F(异亮氨酸到苯丙氨酸)上发现了大量的无义突变。其他重要的突变有R27C、I198V、T85I、L410F、I559V和P583S。I120F突变在澳大利亚分离株中大量存在,在孟加拉国和美国等其他国家也有传播。我们认为,Nsp2拓扑异构酶丰富的I120F突变可能通过稳定RNA结构以提高病毒包装效率来增加冠状病毒的传播。有趣的是,这些突变被发现与穗蛋白D614G突变相关,已知该突变可使感染性增加70%以上。相反,所有的P583S Nsp2突变体都没有并发的D614G刺突蛋白突变。全基因组分析检测到许多沉默突变(5-7),但未发现N501Y刺突蛋白突变。这是第一份预测冠状病毒传播与Nsp2蛋白I120F和刺突蛋白D614G突变有关的报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
siRNA-Inhibition of TIGAR Hypersensitizes Human Papillomavirus-Transformed Cells to Apoptosis Induced by Chemotherapy Drugs that Cause Oxidative Stress Coroless, effective ingredient isolated from traditional Chinese medicine for the prevention and treatment of Covid-19 An Exploratory Study on COVID-19 and the Rights of Children Based on Keyword Network Analysis Comorbidities of COVID-19 Patients with Low Cycle Threshold (Ct) Value of Nucleocapsid (N) Gene: An Application to Cluster-Based Logistic Model. A Questionnaire-Based Survey to Assess the Timing of Intubation in COVID-19 Pneumonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1